BOSTON (Oct. 24, 2024) – Anaphylaxis can come on suddenly and without warning, and because its symptoms can be fatal, it is scary for those who encounter it. Two new studies being presented at this ...
neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children aged 4 years and older who weigh at least 33 pounds (15 kg) ...
Misinformation and outdated protocols contribute to the suboptimal management of anaphylaxis by patients and healthcare professionals, based on data from two new studies presented at the American ...
An international panel of experts has developed standardized definitions and treatment protocols for anaphylaxis, aiming to eliminate long-standing inconsistencies in emergency care. The Global ...
Approximately 2% of adults and 4% to 8% of children have food allergies in the U.S., with food-induced anaphylaxis resulting in roughly 30,000 emergency department visits, 2,000 hospitalizations, and ...
“Outdated protocols” and a lack of patient education around anaphylaxis treatment can result in poor patient outcomes, Medscape Medical News reported Oct. 28. A survey of 96 patients and caregivers ...
The Healthy @Reader's Digest on MSN
What I wish I’d known about allergic anaphylaxis: A patient’s story, with an expert doctor’s insights
Despite his best effort to check food labels, one college student details his close call with anaphylaxis and what he learned ...
Neffy, a nasal spray alternative to the EpiPen and similar injectables, has been approved by the FDA. The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has ...
Please provide your email address to receive an email when new articles are posted on . Less than half of physicians identified gastrointestinal and upper respiratory tract symptoms as potential signs ...
Anaphylaxis is a severe, life threatening allergic reaction; but now, there are new recommendations on how to improve treatment. Anaphylaxis can progress quickly and could be deadly if the life-saving ...
ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...
Please provide your email address to receive an email when new articles are posted on . Most anaphylactic reactions were moderate and occurred during the up-dosing phase of OIT treatment. About half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback